Table 2.
Open in new tab

Odds ratios of fracture risk among the 3 populations; controls versus 2 forms of primary hyperparathyroidism

Crude (95% CI)Adjusted (95% CI)a
Evidence of fracture
Controls11
Normocalcemic1.27 (0.48-3.49)1.32 (0.48-3.72)
Hypercalcemic5.00 (1.94-13.85)5.87 (2.16-17.3)
Evidence of moderate–severe fractures
Controls11
Normocalcemic1.04 (0.26-4.49)1.04 (0.25-4.55)
Hypercalcemic3.75 (1.16-14.59)3.81 (1.15-15.12)
Crude (95% CI)Adjusted (95% CI)a
Evidence of fracture
Controls11
Normocalcemic1.27 (0.48-3.49)1.32 (0.48-3.72)
Hypercalcemic5.00 (1.94-13.85)5.87 (2.16-17.3)
Evidence of moderate–severe fractures
Controls11
Normocalcemic1.04 (0.26-4.49)1.04 (0.25-4.55)
Hypercalcemic3.75 (1.16-14.59)3.81 (1.15-15.12)

aModels adjusted for age.

Table 2.
Open in new tab

Odds ratios of fracture risk among the 3 populations; controls versus 2 forms of primary hyperparathyroidism

Crude (95% CI)Adjusted (95% CI)a
Evidence of fracture
Controls11
Normocalcemic1.27 (0.48-3.49)1.32 (0.48-3.72)
Hypercalcemic5.00 (1.94-13.85)5.87 (2.16-17.3)
Evidence of moderate–severe fractures
Controls11
Normocalcemic1.04 (0.26-4.49)1.04 (0.25-4.55)
Hypercalcemic3.75 (1.16-14.59)3.81 (1.15-15.12)
Crude (95% CI)Adjusted (95% CI)a
Evidence of fracture
Controls11
Normocalcemic1.27 (0.48-3.49)1.32 (0.48-3.72)
Hypercalcemic5.00 (1.94-13.85)5.87 (2.16-17.3)
Evidence of moderate–severe fractures
Controls11
Normocalcemic1.04 (0.26-4.49)1.04 (0.25-4.55)
Hypercalcemic3.75 (1.16-14.59)3.81 (1.15-15.12)

aModels adjusted for age.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close